|
1
|
Ibrahim MA, Kelleni M and Geddawy A:
Nonalcoholic fatty liver disease: Current and potential therapies.
Life Sci. 92:114–118. 2013. View Article : Google Scholar
|
|
2
|
Henao-Mejia J, Elinav E, Jin C, Hao L,
Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ,
et al: Inflammasome-mediated dysbiosis regulates progression of
NAFLD and obesity. Nature. 482:179–185. 2012.PubMed/NCBI
|
|
3
|
Rezazadeh A, Yazdanparast R and Molaei M:
Amelioration of diet-induced nonalcoholic steatohepatitis in rats
by Mnsalen complexes via reduction of oxidative stress. J Biomed
Sci. 19:262012. View Article : Google Scholar
|
|
4
|
Shaker M, Tabbaa A, Albeldawi M and
Alkhouri N: Liver transplantation for nonalcoholic fatty liver
disease: New challenges and new opportunities. World J
Gastroenterol. 20:5320–5330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagaishi K, Ataka K, Echizen E, Arimura Y
and Fujimiya M: Mesenchymal stem cell therapy ameliorates diabetic
hepatocyte damage in mice by inhibiting infiltration of bone
marrow-derived cells. Hepatology. 59:1816–1829. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Banas A, Teratani T, Yamamoto Y, Tokuhara
M, Takeshita F, Quinn G, Okochi H and Ochiya T: Adipose
tissue-derived mesenchymal stem cells as a source of human
hepatocytes. Hepatology. 46:219–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kubo N, Narumi S, Kijima H, Mizukami H,
Yagihashi S, Hakamada K and Nakane A: Efficacy of adipose
tissue-derived mesenchymal stem cells for fulminant hepatitis in
mice induced by concanavalin A. J Gastroenterol Hepatol.
27:165–172. 2012. View Article : Google Scholar
|
|
8
|
Ghannam S, Bouffi C, Djouad F, Jorgensen C
and Noël D: Immunosuppression by mesenchymal stem cells: Mechanisms
and clinical applications. Stem Cell Res Ther. 1:22010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun CK, Chang CL, Lin YC, Kao YH, Chang
LT, Yen CH, Shao PL, Chen CH, Leu S and Yip HK: Systemic
administration of autologous adipose-derived mesenchymal stem cells
alleviates hepatic ischemia-reperfusion injury in rats. Crit Care
Med. 40:1279–1290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meyerrose TE, De Ugarte DA, Hofling AA,
Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands
MS, Hedrick MA, et al: In vivo distribution of human
adipose-derived mesenchymal stem cells in novel xenotransplantation
models. Stem Cells. 25:220–227. 2007. View Article : Google Scholar
|
|
11
|
Philippe B, Luc S, Valérie PB, Jérôme R,
Alessandra BR and Louis C: Culture and use of mesenchymal stromal
cells in phase I and II clinical trials. Stem Cells Int.
2010:5035932010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Chen XM and Sun DL: Effects of
coencapsulation of hepatocytes with adipose-derived stem cells in
the treatment of rats with acute-on-chronic liver failure. Int J
Artif Organs. 37:133–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saito Y, Shimada M, Utsunomiya T, Ikemoto
T, Yamada S, Morine Y, Imura S, Mori H, Sugimoto K, Iwahashi S, et
al: The protective effect of adipose-derived stem cells against
liver injury by trophic molecules. J Surg Res. 180:162–168. 2013.
View Article : Google Scholar
|
|
14
|
Harn HJ, Lin SZ, Hung SH, Subeq YM, Li YS,
Syu WS, Ding DC, Lee RP, Hsieh DK, Lin PC, et al: Adipose-derived
stem cells can abrogate chemical-induced liver fibrosis and
facilitate recovery of liver function. Cell Transplant.
21:2753–2764. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liedtke C, Luedde T, Sauerbruch T,
Scholten D, Streetz K, Tacke F, Tolba R, Trautwein C, Trebicka J
and Weiskirchen R: Experimental liver fibrosis research: Update on
animal models, legal issues and translational aspects. Fibrogenesis
Tissue Repair. 6:192013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nanji AA and French SW: Animal models of
alcoholic liver disease - focus on the intragastric feeding model.
Alcohol Res Health. 27:325–330. 2003.
|
|
17
|
Seki A, Sakai Y, Komura T, Nasti A,
Yoshida K, Higashimoto M, Honda M, Usui S, Takamura M, Takamura T,
et al: Adipose tissue-derived stem cells as a regenerative therapy
for a mouse steatohepatitis-induced cirrhosis model. Hepatology.
58:1133–1142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vernon G, Baranova A and Younossi ZM:
Systematic review: The epidemiology and natural history of
non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
in adults. Aliment Pharmacol Ther. 34:274–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Milagro FI, Campión J and Martínez JA:
Weight gain induced by high-fat feeding involves increased liver
oxidative stress. Obesity (Silver Spring). 14:1118–1123. 2006.
View Article : Google Scholar
|
|
20
|
Stauffer JK, Scarzello AJ, Jiang Q and
Wiltrout RH: Chronic inflammation, immune escape, and oncogenesis
in the liver: A unique neighborhood for novel intersections.
Hepatology. 56:1567–1574. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Budhu A and Wang XW: The role of cytokines
in hepatocellular carcinoma. J Leukoc Biol. 80:1197–1213. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Lian F, Li J, Fan W, Xu H, Yang X,
Liang L, Chen W and Yang J: Adipose derived mesenchymal stem cells
transplantation via portal vein improves microcirculation and
ameliorates liver fibrosis induced by CCl4 in rats. J Transl Med.
10:1332012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ezquer M, Ezquer F, Ricca M, Allers C and
Conget P: Intravenous administration of multipotent stromal cells
prevents the onset of non-alcoholic steatohepatitis in obese mice
with metabolic syndrome. J Hepatol. 55:1112–1120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Winkler S, Borkham-Kamphorst E, Stock P,
Brückner S, Dollinger M, Weiskirchen R and Christ B: Human
mesenchymal stem cells towards non-alcoholic steatohepatitis in an
immunodeficient mouse model. Exp Cell Res. 326:230–239. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gaggini M, Morelli M, Buzzigoli E,
DeFronzo RA, Bugianesi E and Gastaldelli A: Non-alcoholic fatty
liver disease (NAFLD) and its connection with insulin resistance,
dyslipidemia, atherosclerosis and coronary heart disease.
Nutrients. 5:1544–1560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takaki A, Kawai D and Yamamoto K:
Molecular mechanisms and new treatment strategies for non-alcoholic
steatohepatitis (NASH). Int J Mol Sci. 15:7352–7379. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mollica MP, Lionetti L, Moreno M, Lombardi
A, De Lange P, Antonelli A, Lanni A, Cavaliere G, Barletta A and
Goglia F: 3,5-diiodo-l-thyronine, by modulating mitochondrial
functions, reverses hepatic fat accumulation in rats fed a high-fat
diet. J Hepatol. 51:363–370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y,
Zhang L and Wang Y: High-fat emulsion-induced rat model of
nonalcoholic steatohepatitis. Life Sci. 79:1100–1107. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Asrih M and Jornayvaz FR: Inflammation as
a potential link between nonalcoholic fatty liver disease and
insulin resistance. J Endocrinol. 218:R25–R36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Del Ben M, Polimeni L, Carnevale R,
Bartimoccia S, Nocella C, Baratta F, Loffredo L, Pignatelli P,
Violi F and Angelico F: NOX2-generated oxidative stress is
associated with severity of ultrasound liver steatosis in patients
with non-alcoholic fatty liver disease. BMC Gastroenterol.
14:812014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meli R, MattaceRaso G and Calignano A:
Role of Innate Immune Response in Non-Alcoholic Fatty Liver
Disease: Metabolic Complications and TherapeuticTools. Front
Immunol. 5:1772014. View Article : Google Scholar
|
|
32
|
Jung UJ and Choi MS: Obesity and its
metabolic complications: The role of adipokines and the
relationship between obesity, inflammation, insulin resistance,
dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci.
15:6184–6223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J, Liu D, Bai Q, Song J, Guan J, Gao
J, Liu B, Ma X and Du Y: Celecoxib attenuates liver steatosis and
inflammation in non-alcoholic steatohepatitis induced by high-fat
diet in rats. Mol Med Rep. 4:811–816. 2011.PubMed/NCBI
|
|
34
|
Giannitrapani L, Ingrao S, Soresi M,
Florena AM, La Spada E, Sandonato L, D'Alessandro N, Cervello M and
Montalto G: Cyclooxygenase-2 expression in chronic liver diseases
and hepatocellular carcinoma: An immunohistochemical study. Ann N Y
Acad Sci. 1155:293–299. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Seki T, Yokoyama Y, Nagasaki H, Kokuryo T
and Nagino M: Adipose tissue-derived mesenchymal stem cell
transplantation promotes hepatic regeneration after hepatic
ischemia-reperfusion and subsequent hepatectomy in rats. J Surg
Res. 178:63–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
